Stay updated on Immunotherapy Platform in Platinum-Resistant Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the Immunotherapy Platform in Platinum-Resistant Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Immunotherapy Platform in Platinum-Resistant Ovarian Cancer Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The study page now renders a 403 Forbidden error instead of the study details, effectively blocking access to the IPROC record. The visible content shows a standard 403 layout and message.
    Difference
    20%
    Check dated 2026-09-22T23:10:02.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    Adds a 'Find contact information' navigation label and updates the page to revision v3.7.0. This replaces the previous 'Find Contact Information' label and v3.6.6 revision.
    Difference
    0.1%
    Check dated 2026-09-15T21:59:00.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The page footer now shows Revision: v3.6.6, replacing the previous Revision: v3.6.5. This reflects a minor system/template update rather than a substantive change to the study details.
    Difference
    0.0%
    Check dated 2026-09-01T19:35:12.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.4 to v3.6.5. This represents a new platform build release, typically reflecting maintenance or bug fixes rather than changes to study details.
    Difference
    0.0%
    Check dated 2026-08-11T15:32:45.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    A Publications section and a Study Results entry were added, including a citation for the IPROC sub-studies results. The page shows a new revision tag (v3.6.4) dated 2026-07-20, updating the study record with recent results dissemination.
    Difference
    0.4%
    Check dated 2026-07-28T04:58:54.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    The listing now identifies ovarian cancer as the condition, links related topics, and updates the study's location count to 6 locations with milestone dates such as 2026-07-14 and 2026-12-31. Additionally, outdated contact details and a Montreal location entry were removed, accompanying a change in reported locations from 7 to 6 and a revised recruitment status.
    Difference
    0.8%
    Check dated 2026-07-21T01:45:38.000Z thumbnail image

Stay in the know with updates to Immunotherapy Platform in Platinum-Resistant Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Immunotherapy Platform in Platinum-Resistant Ovarian Cancer Clinical Trial page.